You are here:
Therapeutic
Areas
DECADES OF EXPERIENCE IN THESE THERAPEUTIC AREAS
When conducting studies in patients our flagship offerings are in HIV and TB as well as other Infectious Disease Vaccines and Therapeutics. Our execution partners have recently played a major role in recruiting large patient cohorts (>25,000 randomised) in several SARS-CoV-2 vaccine studies.
When conducting healthy volunteer studies, we offer First-in-Man and Bioequivalence studies as our flagship offerings. We offer a comprehensive bio-analytical laboratory service, packaged with the clinical procedures, or provided as standalone service.
In addition to the above, we can also deliver on select chronic disease therapeutic areas specialising in proof-of-concept (Phase 2a) studies in these therapeutic areas.
